Moreover, the TG analysis confirmed the lipid-lowering effects of both gardenoside and si-CTCF as reflected by the decrease of TG in these groups (Figure 3B), indicating that gardenoside, as well as si-CTCF, may exert hepatoprotective effects in NAFLD. This evidence concerns the gene CTCF and metabolic dysfunction-associated steatotic liver disease.